Home・Listă Acțiuni・Insulet Corp

Insulet Corp

Închisă

SectorSănătate

132.62 -20.36

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

126.5

Maxim

165.98

Indicatori cheie
By Trading Economics
Venit	-11M 91M
Vânzări	-22M 762M
P/E Medie Sector	39.65 68.51
EPS	1.42
Marjă de profit	11.96
Angajați	5,400
EBITDA	-23M 154M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+22.86% upside

Dividende
By Acuity
Următoarele câștiguri	5 nov. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-117M 12B
Deschiderea anterioară	152.98
Închiderea anterioară	132.62

Insulet Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

5 aug. 2026, 23:46 UTC

Insulet Corp. shares traded lower in after-market hours, reflecting routine activity and cautious market sentiment amid disappointing private sector employment data.

4 aug. 2026, 23:56 UTC

Insulet Corp shares are lower in after-market hours, showing little change since Tuesday's close amid a lack of specific company news.

3 aug. 2026, 19:36 UTC

Correlated Moves

Insulet Corp's shares are higher today, supported by a positive trend in the medical devices sector. The stock remains above its 20-day moving average.

31 iul. 2026, 20:06 UTC

News

Insulet Corp shares are declining amid a securities class action lawsuit alleging misrepresentations about the safety of its Omnipod products.

29 iul. 2026, 18:43 UTC

Insulet Corp shares are higher, driven by gains in the Health Care Equipment sub-sector. The stock remains well above its 20-day moving average.

28 iul. 2026, 19:06 UTC

Correlated Moves

Insulet Corp shares are trading higher, benefiting from a significant rise in the Health Care Equipment sub-sector and ongoing momentum above their 20-day moving average.

27 iul. 2026, 20:06 UTC

Insulet Corp shares are higher today, reflecting broader market trends despite an earlier pullback from a session high. No specific news was identified.

24 iul. 2026, 22:26 UTC

Insulet Corp shares are lower in after-market hours, following a decline from earlier session lows. No specific company news was identified to explain the movement.

22 iul. 2026, 20:01 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities fraud related to safety claims about its Omnipod products.

20 iul. 2026, 18:36 UTC

News

Insulet Corp is gaining today after being identified as a healthcare stock likely to deliver sustainable market-beating returns, despite ongoing legal challenges.

Comparație

Modificare preț

Insulet Corp Așteptări

Obiectiv de preț

By TipRanks

22.86% sus

Prognoză pe 12 luni

Medie 204.95 USD 22.86%

Maxim 275 USD

Minim 144 USD

În baza a 22 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruInsulet Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

22 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 22 analiști care au acordat evaluări ale acțiunilor Insulet Corp - Dist în ultimele 3 luni.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.